Pfizer CEO Says Allocation of Covid Pill Will Be Fair

The transcript discusses the anticipated FDA approval for a COVID pill, manufacturing plans, and global distribution strategies. It highlights the importance of equitable access to vaccines, pricing negotiations with governments, and the potential role of generic manufacturing. The speaker emphasizes the necessity of vaccines despite the availability of a COVID pill, addressing concerns about public perception and health safety.

What is the significance of the contract signed with the US government regarding vaccine distribution?

How does the company plan to scale up production of the COVID pill?

What is the response to concerns that people might rely on the COVID pill instead of getting vaccinated?